EDElisa Domínguez-Hüttinger

Elisa Domínguez-Hüttinger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Elisa Domínguez-Hüttinger has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Reiko J. Tanaka

    Department of Bioengineering, Imperial College London, London, United Kingdom

    8 shared publications
  • Eliezer Flores-Garza

    Affiliation Department of Bioengineering, Imperial College London, South Kensington Campus, London, United Kingdom

    5 shared publications
  • Ibrahim García-Zárate

    Facultad de Ciencias, Universidad Nacional Autónoma de México, Ciudad Universitaria, Mexico City, Mexico

    3 shared publications
  • Pablo Aguirre

    Departamento de Matemática, Universidad Técnica Federico Santa Mariá, Valparaiso, Chile

    3 shared publications
  • Panayiotis Christodoulides

    Department of Bioengineering, Imperial College London, London SW7 2AZ, UK

    3 shared publications
  • Rogelio Hernández-Pando

    Sección de Patología Experimental, Departamento de Patología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

    3 shared publications

Latest Publications

  • Open Access

    History-dependent switch-like differentiation of keratinocytes in response to skin barrier damage

    by Elisa Domíguez-Hüttinger, Eliezer Flores-Garza, José Luis Caldú-Primo, Harley Day, Abihail Roque Ramírez, Reiko J. Tanaka

    The epidermis is formed by layers of keratinocytes with increasing levels of differentiation towards the outer skin called skin barrier, which protects our body from environmental stressors and dehydration. When skin barrier is damaged, keratinocyte differentiation is triggered, and terminally differentiated keratinocytes express skin barrier components, achieving skin barrier homeostasis. However, the dynamic and quantitative understanding of how skin barrier homeostasis is achieved remains unknown. To elucidate how keratinocyte differentiation is dynamically affected by skin barrier damage, especially in the presence of infection, we developed a mechanistic model of keratinocyte differentiation by integrating experimental results from 101 manually curated publications. To extract the key regulatory structure of the model, we applied model reduction, called the kernel reduction methodology to obtain the minimal reaction network. The key regulatory structure is characterised by positive feedback with cooperativity between Np63 and Stat3, two master regulators of keratinocyte differentiation. This regulatory structure gives rise to bistable behaviour for the expression of terminal differentiation markers of keratinocytes when the skin barrier is damaged and the extracellular calcium level is varied. We validated the model by confirming it produces the history-dependent and switch-like keratinocyte differentiation observed in in vitro reversibility assays. Analysis of the validated model shows that bacterial infection augments keratinocytes’ sensitivity to skin barrier damage by decreasing the level required for differentiation and de-differentiation. Our results suggest the mechanisms by which skin barrier homeostasis is maintained even when the skin is exposed to fluctuating environments that perturb the barrier composition. We propose and validate a mechanistic mathematical model that can uncover how keratinocyte differentiation is affected by skin barrier damage and infection. Our model represents the key regulatory structure of the complex network of biochemical interactions that map infectious microenvironments to keratinocyte differentiation states. We identify a keratinocyte differentiation motif, the key regulatory structure of the model, by applying systematic model reduction. The motif comprises positive feedback and cooperativity, which gives rise to a bistable dose-response behaviour for keratinocyte differentiation in response to skin barrier damage. We validate our model by confirming it reproduces the results of in vitro keratinocyte differentiation assays. Model analysis shows that innate immune responses triggered by infection decreases the threshold levels required for differentiation and de-differentiation, making keratinocyte differentiation more sensitive to skin barrier damage. These results help elucidate how infectious skin microenvironments trigger the dynamic regulation of keratinocyte differentiation and understand the role of infection in skin diseases such as eczema and psoriasis on epidermal barrier homeostasis.


  • Open Access

    Publisher Correction: Bifurcation analysis of a tuberculosis progression model for drug target identification

    by Eliezer Flores-Garza, Rogelio Hernández-Pando, Ibrahim García-Zárate, Pablo Aguirre, Elisa Domínguez-Hüttinger


  • Open Access

    Bifurcation analysis of a tuberculosis progression model for drug target identification

    by Eliezer Flores-Garza, Rogelio Hernández-Pando, Ibrahim García-Zárate, Pablo Aguirre, Elisa Domínguez-Hüttinger

    Tuberculosis (TB) is a major cause of morbidity and mortality worldwide. The emergence and rapid spread of drug-resistant M. tuberculosis strains urge us to develop novel treatments. Experimental trials are constrained by laboratory capacity, insufficient funds, low number of laboratory animals and obsolete technology. Systems-level approaches to quantitatively study TB can overcome these limitations. Previously, we proposed a mathematical model describing the key regulatory mechanisms underlying the pathological progression of TB. Here, we systematically explore the effect of parameter variations on disease outcome. We find five bifurcation parameters that steer the clinical outcome of TB: number of bacteria phagocytosed per macrophage, macrophages death, macrophage killing by bacteria, macrophage recruitment, and phagocytosis of bacteria. The corresponding bifurcation diagrams show all-or-nothing dose–response curves with parameter regions mapping onto bacterial clearance, persistent infection, or history-dependent clearance or infection. Importantly, the pathogenic stage strongly affects the sensitivity of the host to these parameter variations. We identify parameter values corresponding to a latent-infection model of TB, where disease progression occurs significantly slower than in progressive TB. Two-dimensional bifurcation analyses uncovered synergistic parameter pairs that could act as efficient compound therapeutic approaches. Through bifurcation analysis, we reveal how modulation of specific regulatory mechanisms could steer the clinical outcome of TB.


  • Open Access

    Bifurcation analysis of a tuberculosis progression model for drug target identification

    by Eliezer Flores-Garza, Rogelio Hernández-Pando, Ibrahim García-Zárate, Pablo Aguirre, Elisa Domínguez-Hüttinger

    Tuberculosis (TB) is a major cause of morbidity and mortality worldwide. The emergence and rapid spread of drug-resistant M. tuberculosis strains urge us to develop novel treatments. Experimental assays are restricted by lab capacity, insufficient funds, low numbers of laboratory animals and obsolete technology. Systems-level approaches to quantitatively study TB can overcome these limitations. Previously, we proposed a mathematical model describing the key regulatory mechanisms underlying the pathological progression of TB. Here, we systematically explore the effect of parameter variations on disease outcome. We find five bifurcation parameters that steer the clinical outcome of TB: number of bacteria phagocytized per macrophage, macrophages death, macrophage killing by bacteria, macrophage recruitment, and phagocytosis of bacteria. The corresponding bifurcation diagrams show all-or-nothing dose-response curves with parameter regions mapping onto bacterial clearance, persistent infection, or history-dependent clearance or infection. Importantly, pathogenic stage strongly affects the host’s sensitivity to these parameter variations. We identify parameter values corresponding to a latent-infection model of TB, where disease progression occurs significantly slower than in progressive TB. Two-dimensional bifurcation analyses uncovered synergistic parameter pairs which could act as efficient compound therapeutic approaches. Through bifurcation analysis, we reveal how modulating specific regulatory mechanisms could steer the clinical outcome of TB.

  • Open Access

    Mathematical Model of the Immunopathological Progression of Tuberculosis

    by Eliezer Flores-Garza, Mario A Zetter, Rogelio Hernández-Pando, Elisa Domínguez-Hüttinger

    Tuberculosis is a worldwide persistent infectious disease. It is caused by bacteria from the Mycobacterium tuberculosis complex that mainly affects the lungs and can be fatal. Using an integrative systems biology approach, we study the immunopathological progression of this disease, analyzing the key interactions between the cells involved in the different phases of the infectious process. We integrated multiple in vivo and in vitro data from immunohistochemical, serological, molecular biology, and cell count assays into a mechanistic mathematical model. The ordinary differential equation (ODE) model captures the regulatory interplay between the phenotypic variation of the main cells involved in the disease progression and the inflammatory microenvironment. The model reproduces in vivo time course data of an experimental model of progressive pulmonary TB in mouse, accurately reflecting the functional adaptations of the host–pathogen interactions as the disease progresses through three phenotypically different phases. We used the model to assess the effect of genotypic variations (encoded as changes in parameters) on disease outcomes. For all genotypes, we found an all-or-nothing response, where the virtual mouse either completely clears the infection or suffers uncontrolled Tb growth. Results show that it is 84% probable that a mouse submitted to a progressive pulmonary TB assay will end up with an uncontrolled infection. The simulations also showed how the genotypic variations shape the transitions across phases, showing that 100% of the genotypes evaluated eventually progress to phase two of the disease, suggesting that adaptive immune response activation was unavoidable. All the genotypes of the network that avoided progressing to phase 3 cleared the infection. Later, by analyzing the three different phases separately, we saw that the anti-inflammatory genotype of phase 3 was the one with the highest probability of leading to uncontrolled bacterial growth, and the proinflammatory genotype associated with phase 2 had the highest probability of bacterial clearance. Forty-two percent of the genotypes evaluated showed a bistable response, with one stable steady state corresponding to infection clearance and the other one to bacteria reaching its carrying capacity. Our mechanistic model can be used to predict the outcomes of different experimental conditions through in silico assays.


  • Open Access

    Personalized prediction of daily eczema severity scores using a mechanistic machine learning model

    by Guillem Hurault, Elisa Domínguez‐Hüttinger, Sinéad M. Langan, Hywel C. Williams, Reiko J. Tanaka

    Background: Atopic dermatitis (AD) is a chronic inflammatory skin disease with periods of flares and remission. Designing personalized treatment strategies for AD is challenging, given the apparent unpredictability and large variation in AD symptoms and treatment responses within and across individuals. Better prediction of AD severity over time for individual patients could help to select optimum timing and type of treatment for improving disease control.Objective: We aimed to develop a proof of principle mechanistic machine learning model that predicts the patient‐specific evolution of AD severity scores on a daily basis.Methods: We designed a probabilistic predictive model and trained it using Bayesian inference with the longitudinal data from two published clinical studies. The data consisted of daily recordings of AD severity scores and treatments used by 59 and 334 AD children over 6 months and 16 weeks, respectively. Validation of the predictive model was conducted in a forward‐chaining setting.Results: Our model was able to predict future severity scores at the individual level and improved chance‐level forecast by 60%. Heterogeneous patterns in severity trajectories were captured with patient‐specific parameters such as the short‐term persistence of AD severity and responsiveness to topical steroids, calcineurin inhibitors and step‐up treatment.Conclusions: Our proof of principle model successfully predicted the daily evolution of AD severity scores at an individual level and could inform the design of personalized treatment strategies that can be tested in future studies. Our model‐based approach can be applied to other diseases with apparent unpredictability and large variation in symptoms and treatment responses such as asthma.


  • Open Access

    Bifurcation analysis of a mathematical model of atopic dermatitis to determine patient-specific effects of treatments on dynamic phenotypes

    by Gouhei Tanaka, Elisa Domínguez-Hüttinger, Panayiotis Christodoulides, Kazuyuki Aihara, Reiko J. Tanaka


  • Open Access

    Mathematical modeling of atopic dermatitis reveals “double-switch” mechanisms underlying 4 common disease phenotypes

    by Elisa Domínguez-Hüttinger, Panayiotis Christodoulides, Kosuke Miyauchi, Alan D. Irvine, Mariko Okada-Hatakeyama, Masato Kubo, Reiko J. Tanaka


  • Open Access

    Computational design of treatment strategies for proactive therapy on atopic dermatitis using optimal control theory

    by Panayiotis Christodoulides, Yoshito Hirata, Elisa Domínguez-Hüttinger, Simon G. Danby, Michael J. Cork, Hywel C. Williams, Kazuyuki Aihara, Reiko J. Tanaka

    Atopic dermatitis (AD) is a common chronic skin disease characterized by recurrent skin inflammation and a weak skin barrier, and is known to be a precursor to other allergic diseases such as asthma. AD affects up to 25% of children worldwide and the incidence continues to rise. There is still uncertainty about the optimal treatment strategy in terms of choice of treatment, potency, duration and frequency. This study aims to develop a computational method to design optimal treatment strategies for the clinically recommended ‘proactive therapy’ for AD. Proactive therapy aims to prevent recurrent flares once the disease has been brought under initial control. Typically, this is done by using an anti-inflammatory treatment such as a potent topical corticosteroid intensively for a few weeks to ‘get control’, followed by intermittent weekly treatment to suppress subclinical inflammation to ‘keep control’. Using a hybrid mathematical model of AD pathogenesis that we recently proposed, we computationally derived the optimal treatment strategies for individual virtual patient cohorts, by recursively solving optimal control problems using a differential evolution algorithm. Our simulation results suggest that such an approach can inform the design of optimal individualized treatment schedules that include application of topical corticosteroids and emollients, based on the disease status of patients observed on their weekly hospital visits. We demonstrate the potential and the gaps of our approach to be applied to clinical settings. This article is part of the themed issue ‘Mathematical methods in medicine: neuroscience, cardiology and pathology’.


  • Open Access

    Mathematical Modeling of Streptococcus pneumoniae Colonization, Invasive Infection and Treatment

    by Elisa Domínguez-Hüttinger, Neville J. Boon, Thomas B. Clarke, Reiko J. Tanaka

    Streptococcus pneumoniae (Sp) is a commensal bacterium that normally resides on the upper airway epithelium without causing infection. However, factors such as co-infection with influenza virus can impair the complex Sp-host interactions and the subsequent development of many life-threatening infectious and inflammatory diseases, including pneumonia, meningitis or even sepsis. With the increased threat of Sp infection due to emergence of new antibiotic resistant Sp strains, there is an urgent need for better treatment strategies that effectively prevent progression of disease triggered by Sp infection, minimizing the use of antibiotics. The complexity of the host-pathogen interactions has left the full understanding of underlying mechanisms of Sp-triggered pathogenesis as a challenge, despite its critical importance in the identification of effective treatments. To achieve a systems-level and quantitative understanding of the complex and dynamically-changing host-Sp interactions, here we developed a mechanistic mathematical model describing dynamic interplays between Sp, immune cells, and epithelial tissues, where the host-pathogen interactions initiate. The model serves as a mathematical framework that coherently explains various in vitro and in vivo studies, to which the model parameters were fitted. Our model simulations reproduced the robust homeostatic Sp-host interaction, as well as three qualitatively different pathogenic behaviours: immunological scarring, invasive infection and their combination. Parameter sensitivity and bifurcation analyses of the model identified the processes that are responsible for qualitative transitions from healthy to such pathological behaviours. Our model also predicted that the onset of invasive infection occurs within less than 2 days from transient Sp challenges. This prediction provides arguments in favour of the use of vaccinations, since adaptive immune responses cannot be developed de novo in such a short time. We further designed optimal treatment strategies, with minimal strengths and minimal durations of antibiotics, for each of the three pathogenic behaviours distinguished by our model. The proposed mathematical framework will help to design better disease management strategies and new diagnostic markers that can be used to inform the most appropriate patient-specific treatment options.